| Polyglutamine diseases: the special case of ataxin-3 and Machado–Joseph disease CA Matos, S de Macedo-Ribeiro, AL Carvalho Progress in neurobiology 95 (1), 26-48, 2011 | 168 | 2011 |
| Machado–Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy CA Matos, LP de Almeida, C Nóbrega Journal of neurochemistry 148 (1), 8-28, 2019 | 120 | 2019 |
| MSGP: the first database of the protein components of the mammalian stress granules C Nunes, I Mestre, A Marcelo, R Koppenol, CA Matos, C Nóbrega Database 2019, baz031, 2019 | 62 | 2019 |
| Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models CA Matos, C Nóbrega, SR Louros, B Almeida, E Ferreiro, J Valero, ... Journal of Cell Biology 212 (4), 465-480, 2016 | 48 | 2016 |
| SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97 B Almeida, IA Abreu, CA Matos, JS Fraga, S Fernandes, MG Macedo, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (9 …, 2015 | 46 | 2015 |
| Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado–Joseph disease models A Marcelo, F Brito, S Carmo-Silva, CA Matos, J Alves-Cruzeiro, ... Human Molecular Genetics 28 (1), 51-63, 2019 | 44 | 2019 |
| Proteolytic cleavage of polyglutamine disease-causing proteins: revisiting the toxic fragment hypothesis C A Matos, L Pereira de Almeida, C Nobrega Current Pharmaceutical Design 23 (5), 753-775, 2017 | 39 | 2017 |
| A Handbook of Gene and Cell Therapy C Nóbrega, L Mendonça, CA Matos | 26 | 2020 |
| Gene therapies for polyglutamine diseases CA Matos, V Carmona, UG Vijayakumar, S Lopes, P Albuquerque, ... Polyglutamine Disorders, 395-438, 2018 | 24 | 2018 |
| CYP46A1-gene therapy alleviates spinocerebellar ataxia in mouse models C Nobrega, L Mendonca, A Marcelo, A Lamaziere, S Tome, G Despres, ... HUMAN GENE THERAPY 29 (12), A8-A8, 2018 | | 2018 |
| TALEN and CRISPR Gene-Editing for Treatment of Machado-Joseph Disease S Lopes, R Nobre, C Nobrega, M Lopes, C Matos, N Sanjana, P Hsu, ... MOLECULAR THERAPY 26 (5), 407-407, 2018 | | 2018 |
| Post-translational modifications of Ataxin-3, the protein involved in Machado-Joseph disease C Matos | | 2009 |
